 | • レポートコード：D005-00551 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、IVDの世界市場を広く調査・分析し、今後の市場展望をまとめております。IVDの種類別市場規模（免疫診断、化学診断、分子診断、POCT、その他）、用途別市場規模（糖尿病、感染症、腫瘍学/がん、循環器科、腎臓学、自己免疫疾患、薬物検査/薬理ゲノミクス、HIV/エイズ、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche Diagnostics、Biomérieux Sa、Siemens、Danaher Corporation、Becton, Dickinson and Company、Abbott Laboratories、Johnson & Johnson、Thermo Fisher Scientific、Sysmex、Bio-Rad Laboratories、Agilent Technologies、Ortho Clinical Diagnostics、Qiagen、Diasorin ・地域別グローバル市場分析 2015年-2020年 ・IVDの北米市場（アメリカ、カナダ、メキシコ） ・IVDのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・IVDのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・IVDの南米市場（ブラジル、アルゼンチン） ・IVDの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：免疫診断、化学診断、分子診断、POCT、その他 ・用途別分析：糖尿病、感染症、腫瘍学/がん、循環器科、腎臓学、自己免疫疾患、薬物検査/薬理ゲノミクス、HIV/エイズ、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global IVD market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.6% in the forecast period of 2020 to 2025 and will expected to reach USD 7996.1 million by 2025, from USD 7229.9 million in 2019.
The IVD market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
IVD market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, IVD market has been segmented into:
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Other
By Application, IVD has been segmented into:
Diabetes
Infectious Diseases
Oncology/Cancer
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing/Pharmacogenomics
HIV/AIDS
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global IVD market presented in the report. This section sheds light on the sales growth of different regional and country-level IVD markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global IVD market.
The report offers in-depth assessment of the growth and other aspects of the IVD market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and IVD Market Share Analysis
IVD competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, IVD sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the IVD sales, revenue and market share for each player covered in this report.
The major players covered in IVD are:
Roche Diagnostics
Biomérieux Sa
Siemens
Danaher Corporation
Becton, Dickinson and Company
Abbott Laboratories
Johnson & Johnson
Thermo Fisher Scientific
Sysmex
Bio-Rad Laboratories
Agilent Technologies
Ortho Clinical Diagnostics
Qiagen
Diasorin
Table of Contents
1 IVD Market Overview
1.1 Product Overview and Scope of IVD
1.2 Classification of IVD by Type
1.2.1 Global IVD Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global IVD Revenue Market Share by Type in 2019
1.2.3 Immuno Diagnostics
1.2.4 Chemistry Diagnostics
1.2.5 Molecular Diagnostics
1.2.6 POCT
1.2.7 Other
1.3 Global IVD Market by Application
1.3.1 Overview: Global IVD Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Oncology/Cancer
1.3.5 Cardiology
1.3.6 Nephrology
1.3.7 Autoimmune Diseases
1.3.8 Drug Testing/Pharmacogenomics
1.3.9 HIV/AIDS
1.3.10 Others
1.4 Global IVD Market by Regions
1.4.1 Global IVD Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of IVD (2015-2025)
1.4.3 North America (USA, Canada and Mexico) IVD Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) IVD Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) IVD Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) IVD Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) IVD Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche Diagnostics
2.1.1 Roche Diagnostics Details
2.1.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche Diagnostics SWOT Analysis
2.1.4 Roche Diagnostics Product and Services
2.1.5 Roche Diagnostics IVD Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biomérieux Sa
2.2.1 Biomérieux Sa Details
2.2.2 Biomérieux Sa Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biomérieux Sa SWOT Analysis
2.2.4 Biomérieux Sa Product and Services
2.2.5 Biomérieux Sa IVD Revenue, Gross Margin and Market Share (2018-2019)
2.3 Siemens
2.3.1 Siemens Details
2.3.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Siemens SWOT Analysis
2.3.4 Siemens Product and Services
2.3.5 Siemens IVD Revenue, Gross Margin and Market Share (2018-2019)
2.4 Danaher Corporation
2.4.1 Danaher Corporation Details
2.4.2 Danaher Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Danaher Corporation SWOT Analysis
2.4.4 Danaher Corporation Product and Services
2.4.5 Danaher Corporation IVD Revenue, Gross Margin and Market Share (2018-2019)
2.5 Becton, Dickinson and Company
2.5.1 Becton, Dickinson and Company Details
2.5.2 Becton, Dickinson and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Becton, Dickinson and Company SWOT Analysis
2.5.4 Becton, Dickinson and Company Product and Services
2.5.5 Becton, Dickinson and Company IVD Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott Laboratories
2.6.1 Abbott Laboratories Details
2.6.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott Laboratories SWOT Analysis
2.6.4 Abbott Laboratories Product and Services
2.6.5 Abbott Laboratories IVD Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson SWOT Analysis
2.7.4 Johnson & Johnson Product and Services
2.7.5 Johnson & Johnson IVD Revenue, Gross Margin and Market Share (2018-2019)
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Thermo Fisher Scientific SWOT Analysis
2.8.4 Thermo Fisher Scientific Product and Services
2.8.5 Thermo Fisher Scientific IVD Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sysmex
2.9.1 Sysmex Details
2.9.2 Sysmex Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sysmex SWOT Analysis
2.9.4 Sysmex Product and Services
2.9.5 Sysmex IVD Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bio-Rad Laboratories
2.10.1 Bio-Rad Laboratories Details
2.10.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bio-Rad Laboratories SWOT Analysis
2.10.4 Bio-Rad Laboratories Product and Services
2.10.5 Bio-Rad Laboratories IVD Revenue, Gross Margin and Market Share (2018-2019)
2.11 Agilent Technologies
2.11.1 Agilent Technologies Details
2.11.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Agilent Technologies SWOT Analysis
2.11.4 Agilent Technologies Product and Services
2.11.5 Agilent Technologies IVD Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ortho Clinical Diagnostics
2.12.1 Ortho Clinical Diagnostics Details
2.12.2 Ortho Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Ortho Clinical Diagnostics SWOT Analysis
2.12.4 Ortho Clinical Diagnostics Product and Services
2.12.5 Ortho Clinical Diagnostics IVD Revenue, Gross Margin and Market Share (2018-2019)
2.13 Qiagen
2.13.1 Qiagen Details
2.13.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Qiagen SWOT Analysis
2.13.4 Qiagen Product and Services
2.13.5 Qiagen IVD Revenue, Gross Margin and Market Share (2018-2019)
2.14 Diasorin
2.14.1 Diasorin Details
2.14.2 Diasorin Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Diasorin SWOT Analysis
2.14.4 Diasorin Product and Services
2.14.5 Diasorin IVD Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global IVD Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 IVD Players Market Share
3.2.2 Top 10 IVD Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global IVD Revenue and Market Share by Regions
4.2 North America IVD Revenue and Growth Rate (2015-2020)
4.3 Europe IVD Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific IVD Revenue and Growth Rate (2015-2020)
4.5 South America IVD Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa IVD Revenue and Growth Rate (2015-2020)
5 North America IVD Revenue by Countries
5.1 North America IVD Revenue by Countries (2015-2020)
5.2 USA IVD Revenue and Growth Rate (2015-2020)
5.3 Canada IVD Revenue and Growth Rate (2015-2020)
5.4 Mexico IVD Revenue and Growth Rate (2015-2020)
6 Europe IVD Revenue by Countries
6.1 Europe IVD Revenue by Countries (2015-2020)
6.2 Germany IVD Revenue and Growth Rate (2015-2020)
6.3 UK IVD Revenue and Growth Rate (2015-2020)
6.4 France IVD Revenue and Growth Rate (2015-2020)
6.5 Russia IVD Revenue and Growth Rate (2015-2020)
6.6 Italy IVD Revenue and Growth Rate (2015-2020)
7 Asia-Pacific IVD Revenue by Countries
7.1 Asia-Pacific IVD Revenue by Countries (2015-2020)
7.2 China IVD Revenue and Growth Rate (2015-2020)
7.3 Japan IVD Revenue and Growth Rate (2015-2020)
7.4 Korea IVD Revenue and Growth Rate (2015-2020)
7.5 India IVD Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia IVD Revenue and Growth Rate (2015-2020)
8 South America IVD Revenue by Countries
8.1 South America IVD Revenue by Countries (2015-2020)
8.2 Brazil IVD Revenue and Growth Rate (2015-2020)
8.3 Argentina IVD Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue IVD by Countries
9.1 Middle East & Africa IVD Revenue by Countries (2015-2020)
9.2 Saudi Arabia IVD Revenue and Growth Rate (2015-2020)
9.3 UAE IVD Revenue and Growth Rate (2015-2020)
9.4 Egypt IVD Revenue and Growth Rate (2015-2020)
9.5 South Africa IVD Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global IVD Revenue and Market Share by Type (2015-2020)
10.2 Global IVD Market Forecast by Type (2019-2024)
10.3 Immuno Diagnostics Revenue Growth Rate (2015-2025)
10.4 Chemistry Diagnostics Revenue Growth Rate (2015-2025)
10.5 Molecular Diagnostics Revenue Growth Rate (2015-2025)
10.6 POCT Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global IVD Market Segment by Application
11.1 Global IVD Revenue Market Share by Application (2015-2020)
11.2 IVD Market Forecast by Application (2019-2024)
11.3 Diabetes Revenue Growth (2015-2020)
11.4 Infectious Diseases Revenue Growth (2015-2020)
11.5 Oncology/Cancer Revenue Growth (2015-2020)
11.6 Cardiology Revenue Growth (2015-2020)
11.7 Nephrology Revenue Growth (2015-2020)
11.8 Autoimmune Diseases Revenue Growth (2015-2020)
11.9 Drug Testing/Pharmacogenomics Revenue Growth (2015-2020)
11.10 HIV/AIDS Revenue Growth (2015-2020)
11.11 Others Revenue Growth (2015-2020)
12 Global IVD Market Size Forecast (2021-2025)
12.1 Global IVD Market Size Forecast (2021-2025)
12.2 Global IVD Market Forecast by Regions (2021-2025)
12.3 North America IVD Revenue Market Forecast (2021-2025)
12.4 Europe IVD Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific IVD Revenue Market Forecast (2021-2025)
12.6 South America IVD Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa IVD Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global IVD Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of IVD by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global IVD Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market IVD Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Diagnostics Corporate Information, Location and Competitors
Table 6. Roche Diagnostics IVD Major Business
Table 7. Roche Diagnostics IVD Total Revenue (USD Million) (2017-2018)
Table 8. Roche Diagnostics SWOT Analysis
Table 9. Roche Diagnostics IVD Product and Solutions
Table 10. Roche Diagnostics IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Biomérieux Sa Corporate Information, Location and Competitors
Table 12. Biomérieux Sa IVD Major Business
Table 13. Biomérieux Sa IVD Total Revenue (USD Million) (2018-2019)
Table 14. Biomérieux Sa SWOT Analysis
Table 15. Biomérieux Sa IVD Product and Solutions
Table 16. Biomérieux Sa IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Siemens Corporate Information, Location and Competitors
Table 18. Siemens IVD Major Business
Table 19. Siemens IVD Total Revenue (USD Million) (2017-2018)
Table 20. Siemens SWOT Analysis
Table 21. Siemens IVD Product and Solutions
Table 22. Siemens IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Danaher Corporation Corporate Information, Location and Competitors
Table 24. Danaher Corporation IVD Major Business
Table 25. Danaher Corporation IVD Total Revenue (USD Million) (2017-2018)
Table 26. Danaher Corporation SWOT Analysis
Table 27. Danaher Corporation IVD Product and Solutions
Table 28. Danaher Corporation IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Becton, Dickinson and Company Corporate Information, Location and Competitors
Table 30. Becton, Dickinson and Company IVD Major Business
Table 31. Becton, Dickinson and Company IVD Total Revenue (USD Million) (2017-2018)
Table 32. Becton, Dickinson and Company SWOT Analysis
Table 33. Becton, Dickinson and Company IVD Product and Solutions
Table 34. Becton, Dickinson and Company IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abbott Laboratories Corporate Information, Location and Competitors
Table 36. Abbott Laboratories IVD Major Business
Table 37. Abbott Laboratories IVD Total Revenue (USD Million) (2017-2018)
Table 38. Abbott Laboratories SWOT Analysis
Table 39. Abbott Laboratories IVD Product and Solutions
Table 40. Abbott Laboratories IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Johnson & Johnson Corporate Information, Location and Competitors
Table 42. Johnson & Johnson IVD Major Business
Table 43. Johnson & Johnson IVD Total Revenue (USD Million) (2017-2018)
Table 44. Johnson & Johnson SWOT Analysis
Table 45. Johnson & Johnson IVD Product and Solutions
Table 46. Johnson & Johnson IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 48. Thermo Fisher Scientific IVD Major Business
Table 49. Thermo Fisher Scientific IVD Total Revenue (USD Million) (2017-2018)
Table 50. Thermo Fisher Scientific SWOT Analysis
Table 51. Thermo Fisher Scientific IVD Product and Solutions
Table 52. Thermo Fisher Scientific IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Sysmex Corporate Information, Location and Competitors
Table 54. Sysmex IVD Major Business
Table 55. Sysmex IVD Total Revenue (USD Million) (2017-2018)
Table 56. Sysmex SWOT Analysis
Table 57. Sysmex IVD Product and Solutions
Table 58. Sysmex IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 60. Bio-Rad Laboratories IVD Major Business
Table 61. Bio-Rad Laboratories IVD Total Revenue (USD Million) (2017-2018)
Table 62. Bio-Rad Laboratories SWOT Analysis
Table 63. Bio-Rad Laboratories IVD Product and Solutions
Table 64. Bio-Rad Laboratories IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Agilent Technologies Corporate Information, Location and Competitors
Table 66. Agilent Technologies IVD Major Business
Table 67. Agilent Technologies IVD Total Revenue (USD Million) (2017-2018)
Table 68. Agilent Technologies SWOT Analysis
Table 69. Agilent Technologies IVD Product and Solutions
Table 70. Agilent Technologies IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Ortho Clinical Diagnostics Corporate Information, Location and Competitors
Table 72. Ortho Clinical Diagnostics IVD Major Business
Table 73. Ortho Clinical Diagnostics IVD Total Revenue (USD Million) (2017-2018)
Table 74. Ortho Clinical Diagnostics SWOT Analysis
Table 75. Ortho Clinical Diagnostics IVD Product and Solutions
Table 76. Ortho Clinical Diagnostics IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Qiagen Corporate Information, Location and Competitors
Table 78. Qiagen IVD Major Business
Table 79. Qiagen IVD Total Revenue (USD Million) (2017-2018)
Table 80. Qiagen SWOT Analysis
Table 81. Qiagen IVD Product and Solutions
Table 82. Qiagen IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Diasorin Corporate Information, Location and Competitors
Table 84. Diasorin IVD Major Business
Table 85. Diasorin IVD Total Revenue (USD Million) (2017-2018)
Table 86. Diasorin SWOT Analysis
Table 87. Diasorin IVD Product and Solutions
Table 88. Diasorin IVD Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global IVD Revenue (Million USD) by Players (2015-2020)
Table 90. Global IVD Revenue Share by Players (2015-2020)
Table 91. Global IVD Revenue (Million USD) by Regions (2015-2020)
Table 92. Global IVD Revenue Market Share by Regions (2015-2020)
Table 93. North America IVD Revenue by Countries (2015-2020)
Table 94. North America IVD Revenue Market Share by Countries (2015-2020)
Table 95. Europe IVD Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific IVD Revenue (Million USD) by Countries (2015-2020)
Table 97. South America IVD Revenue by Countries (2015-2020)
Table 98. South America IVD Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa IVD Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa IVD Revenue Market Share by Countries (2015-2020)
Table 101. Global IVD Revenue (Million USD) by Type (2015-2020)
Table 102. Global IVD Revenue Share by Type (2015-2020)
Table 103. Global IVD Revenue Forecast by Type (2021-2025)
Table 104. Global IVD Revenue by Application (2015-2020)
Table 105. Global IVD Revenue Share by Application (2015-2020)
Table 106. Global IVD Revenue Forecast by Application (2021-2025)
Table 107. Global IVD Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. IVD Picture
Figure 2. Global IVD Revenue Market Share by Type in 2019
Figure 3. Immuno Diagnostics Picture
Figure 4. Chemistry Diagnostics Picture
Figure 5. Molecular Diagnostics Picture
Figure 6. POCT Picture
Figure 7. Other Picture
Figure 8. IVD Revenue Market Share by Application in 2019
Figure 9. Diabetes Picture
Figure 10. Infectious Diseases Picture
Figure 11. Oncology/Cancer Picture
Figure 12. Cardiology Picture
Figure 13. Nephrology Picture
Figure 14. Autoimmune Diseases Picture
Figure 15. Drug Testing/Pharmacogenomics Picture
Figure 16. HIV/AIDS Picture
Figure 17. Others Picture
Figure 18. Global IVD Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. North America IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Europe IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Asia-Pacific IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. South America IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Middle East and Africa IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global IVD Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Global IVD Revenue Share by Players in 2019
Figure 26. Global Top 5 Players IVD Revenue Market Share in 2019
Figure 27. Global Top 10 Players IVD Revenue Market Share in 2019
Figure 28. Key Players Market Share Trend
Figure 29. Global IVD Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 30. Global IVD Revenue Market Share by Regions (2015-2020)
Figure 31. Global IVD Revenue Market Share by Regions in 2018
Figure 32. North America IVD Revenue and Growth Rate (2015-2020)
Figure 33. Europe IVD Revenue and Growth Rate (2015-2020)
Figure 34. Asia-Pacific IVD Revenue and Growth Rate (2015-2020)
Figure 35. South America IVD Revenue and Growth Rate (2015-2020)
Figure 36. Middle East and Africa IVD Revenue and Growth Rate (2015-2020)
Figure 37. North America IVD Revenue Market Share by Countries (2015-2020)
Figure 38. North America IVD Revenue Market Share by Countries in 2019
Figure 39. USA IVD Revenue and Growth Rate (2015-2020)
Figure 40. Canada IVD Revenue and Growth Rate (2015-2020)
Figure 41. Mexico IVD Revenue and Growth Rate (2015-2020)
Figure 42. Europe IVD Revenue Market Share by Countries (2015-2020)
Figure 43. Europe IVD Revenue Market Share by Countries in 2019
Figure 44. Germany IVD Revenue and Growth Rate (2015-2020)
Figure 45. UK IVD Revenue and Growth Rate (2015-2020)
Figure 46. France IVD Revenue and Growth Rate (2015-2020)
Figure 47. Russia IVD Revenue and Growth Rate (2015-2020)
Figure 48. Italy IVD Revenue and Growth Rate (2015-2020)
Figure 49. Asia-Pacific IVD Revenue Market Share by Countries (2015-2020)
Figure 50. Asia-Pacific IVD Revenue Market Share by Countries in 2019
Figure 51. China IVD Revenue and Growth Rate (2015-2020)
Figure 52. Japan IVD Revenue and Growth Rate (2015-2020)
Figure 53. Korea IVD Revenue and Growth Rate (2015-2020)
Figure 54. India IVD Revenue and Growth Rate (2015-2020)
Figure 55. Southeast Asia IVD Revenue and Growth Rate (2015-2020)
Figure 56. South America IVD Revenue Market Share by Countries (2015-2020)
Figure 57. South America IVD Revenue Market Share by Countries in 2019
Figure 58. Brazil IVD Revenue and Growth Rate (2015-2020)
Figure 59. Argentina IVD Revenue and Growth Rate (2015-2020)
Figure 60. Middle East and Africa IVD Revenue Market Share by Countries (2015-2020)
Figure 61. Middle East and Africa IVD Revenue Market Share by Countries in 2019
Figure 62. Saudi Arabia IVD Revenue and Growth Rate (2015-2020)
Figure 63. UAE IVD Revenue and Growth Rate (2015-2020)
Figure 64. Egypt IVD Revenue and Growth Rate (2015-2020)
Figure 65. South Africa IVD Revenue and Growth Rate (2015-2020)
Figure 66. Global IVD Revenue Share by Type (2015-2020)
Figure 67. Global IVD Revenue Share by Type in 2019
Figure 68. Global IVD Market Share Forecast by Type (2021-2025)
Figure 69. Global Immuno Diagnostics Revenue Growth Rate (2015-2020)
Figure 70. Global Chemistry Diagnostics Revenue Growth Rate (2015-2020)
Figure 71. Global Molecular Diagnostics Revenue Growth Rate (2015-2020)
Figure 72. Global POCT Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global IVD Revenue Share by Application (2015-2020)
Figure 75. Global IVD Revenue Share by Application in 2019
Figure 76. Global IVD Market Share Forecast by Application (2021-2025)
Figure 77. Global Diabetes Revenue Growth Rate (2015-2020)
Figure 78. Global Infectious Diseases Revenue Growth Rate (2015-2020)
Figure 79. Global Oncology/Cancer Revenue Growth Rate (2015-2020)
Figure 80. Global Cardiology Revenue Growth Rate (2015-2020)
Figure 81. Global Nephrology Revenue Growth Rate (2015-2020)
Figure 82. Global Autoimmune Diseases Revenue Growth Rate (2015-2020)
Figure 83. Global Drug Testing/Pharmacogenomics Revenue Growth Rate (2015-2020)
Figure 84. Global HIV/AIDS Revenue Growth Rate (2015-2020)
Figure 85. Global Others Revenue Growth Rate (2015-2020)
Figure 86. Global IVD Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 87. Global IVD Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 88. Global IVD Revenue Market Share Forecast by Regions (2021-2025)
Figure 89. North America IVD Revenue Market Forecast (2021-2025)
Figure 90. Europe IVD Revenue Market Forecast (2021-2025)
Figure 91. Asia-Pacific IVD Revenue Market Forecast (2021-2025)
Figure 92. South America IVD Revenue Market Forecast (2021-2025)
Figure 93. Middle East and Africa IVD Revenue Market Forecast (2021-2025)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
感染症検査における分子診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics in Infectious Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…- 非侵襲的がん診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Noninvasive Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 127940 million by 2025, from USD 110450 million in 2019. The Nonin…
- 体外診断用医薬品（IVD）の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Vitro Diagnostics (IVD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vitro Diagnostics (IV…
- 膀胱がん治療・診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bladder Cancer Therapeutics and Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 551.5 million by 2025, from USD 427.6 million in 2019…
- 分子診断及びNATの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics and NAT market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Molecular Diagn…